Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients
- PMID: 14605249
- DOI: 10.1203/01.PDR.0000100758.66805.CE
Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients
Abstract
Cystic fibrosis (CF) disease severity is characterized by a broad variability that has been attributed, in addition to the CF transmembrane conductance regulator (CFTR) genotype, to modulating factors such as CFTR-mediated residual chloride (Cl-) secretion. Moreover, CFTR has been suggested to function as a receptor for Pseudomonas aeruginosa (PA). In this study, we investigated whether or not the presence of residual Cl- secretion protects against early chronic PA colonization of patients' airways. Excluding influences on the phenotype caused by different CFTR mutations, we evaluated a cohort of F508del homozygous individuals with respect to the correlation between residual Cl- secretion and the age of onset of PA colonization as an important marker of clinical phenotype. A group with early chronic PA colonization before the age of 7 y (n = 14) was compared with a cohort that had no initial PA detection at least until the age of 13 y (n = 10). We determined the Cl- transport properties by using the intestinal current measurement in rectal suction biopsies. Residual Cl- secretion, most likely due to the CFTR Cl- channel, was observed in 63% of subjects, more frequently in early chronically PA colonized than among late or not colonized patients. These results demonstrate the presence of some active F508del-CFTR in the apical cell membrane and imply that factors other than the CFTR-mediated residual Cl- secretion determine the age of onset of PA colonization.
Similar articles
-
Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.Hepatology. 1999 Jun;29(6):1624-34. doi: 10.1002/hep.510290634. Hepatology. 1999. PMID: 10347100
-
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18. Am J Respir Crit Care Med. 2010. PMID: 20167849
-
Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.J Clin Invest. 2001 Dec;108(11):1705-15. doi: 10.1172/JCI12108. J Clin Invest. 2001. PMID: 11733566 Free PMC article.
-
Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.JOP. 2001 Jul;2(4 Suppl):212-8. JOP. 2001. PMID: 11875262 Review.
-
Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.Wien Klin Wochenschr. 1997 Jun 27;109(12-13):457-64. Wien Klin Wochenschr. 1997. PMID: 9261986 Review.
Cited by
-
DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers.Pulm Pharmacol Ther. 2010 Aug;23(4):268-78. doi: 10.1016/j.pupt.2010.02.001. Epub 2010 Mar 10. Pulm Pharmacol Ther. 2010. PMID: 20226262 Free PMC article.
-
Transcriptional Profiling and Genetic Analysis of a Cystic Fibrosis Airway-Relevant Model Shows Asymmetric Responses to Growth in a Polymicrobial Community.bioRxiv [Preprint]. 2023 May 24:2023.05.24.542191. doi: 10.1101/2023.05.24.542191. bioRxiv. 2023. Update in: Microbiol Spectr. 2023 Sep 29:e0220123. doi: 10.1128/spectrum.02201-23. PMID: 37293107 Free PMC article. Updated. Preprint.
-
Toward inclusive therapy with CFTR modulators: Progress and challenges.Pediatr Pulmonol. 2017 Nov;52(S48):S4-S14. doi: 10.1002/ppul.23773. Epub 2017 Sep 7. Pediatr Pulmonol. 2017. PMID: 28881097 Free PMC article. Review.
-
Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue.Am J Respir Cell Mol Biol. 2010 Nov;43(5):607-16. doi: 10.1165/rcmb.2009-0281OC. Epub 2009 Dec 30. Am J Respir Cell Mol Biol. 2010. PMID: 20042712 Free PMC article.
-
Transcriptional profiling and genetic analysis of a cystic fibrosis airway-relevant model shows asymmetric responses to growth in a polymicrobial community.Microbiol Spectr. 2023 Sep 29;11(5):e0220123. doi: 10.1128/spectrum.02201-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37772884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical